Cardiovascular Risk Score Screening. Miname mh, bittencourt ms, moraes sr, et al. New aspects of cvd risk assessment and management changes to the definition of established cvd or a cvd risk equivalent.
However, these methods are far from perfect. The lifetime risk of atherosclerotic cardiovascular disease (cvd) for persons at age 50 years, on average, is estimated to be 52% for men and 39% for women, with a wide variation depending on risk factor burden. Clearly though, cardiovascular disease begins in early life and with the exposure to risk factors determines a lifetime risk for clinical cardiovascular events.
Cardiovascular disease is the number 1 cause of death in the western world and 1 of the leading causes of death worldwide.
Cardiovascular disease risk assessment in the united states has been generally based on the framingham risk score and, more recently, the pooled cohort equations. Most screening programmes evaluate patients with a high short term risk of developing cardiovascular disease. When people are eligible for this testing, from an insurance perspective, depends on the other risk factors they have, suggesting elevated risk for heart disease. Setting a purposive sample of 12 community pharmacies in three cities in the united arab emirates (uae).
